1. Home
  2. ZURA vs LNZA Comparison

ZURA vs LNZA Comparison

Compare ZURA & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • LNZA
  • Stock Information
  • Founded
  • ZURA 2022
  • LNZA 2005
  • Country
  • ZURA United States
  • LNZA United States
  • Employees
  • ZURA N/A
  • LNZA N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • LNZA Major Chemicals
  • Sector
  • ZURA Health Care
  • LNZA Industrials
  • Exchange
  • ZURA Nasdaq
  • LNZA Nasdaq
  • Market Cap
  • ZURA 69.9M
  • LNZA 65.7M
  • IPO Year
  • ZURA N/A
  • LNZA N/A
  • Fundamental
  • Price
  • ZURA $1.30
  • LNZA $0.29
  • Analyst Decision
  • ZURA Buy
  • LNZA Hold
  • Analyst Count
  • ZURA 7
  • LNZA 2
  • Target Price
  • ZURA $14.33
  • LNZA $2.00
  • AVG Volume (30 Days)
  • ZURA 689.3K
  • LNZA 1.8M
  • Earning Date
  • ZURA 08-08-2025
  • LNZA 08-07-2025
  • Dividend Yield
  • ZURA N/A
  • LNZA N/A
  • EPS Growth
  • ZURA N/A
  • LNZA N/A
  • EPS
  • ZURA N/A
  • LNZA N/A
  • Revenue
  • ZURA N/A
  • LNZA $48,831,000.00
  • Revenue This Year
  • ZURA N/A
  • LNZA $58.17
  • Revenue Next Year
  • ZURA N/A
  • LNZA $10.92
  • P/E Ratio
  • ZURA N/A
  • LNZA N/A
  • Revenue Growth
  • ZURA N/A
  • LNZA N/A
  • 52 Week Low
  • ZURA $0.97
  • LNZA $0.14
  • 52 Week High
  • ZURA $5.07
  • LNZA $2.74
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 58.73
  • LNZA 51.55
  • Support Level
  • ZURA $1.00
  • LNZA $0.27
  • Resistance Level
  • ZURA $1.45
  • LNZA $0.32
  • Average True Range (ATR)
  • ZURA 0.10
  • LNZA 0.03
  • MACD
  • ZURA 0.02
  • LNZA -0.00
  • Stochastic Oscillator
  • ZURA 66.67
  • LNZA 50.54

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About LNZA LanzaTech Global Inc.

LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.

Share on Social Networks: